Related Experiment Video
Updated: Jan 16, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Quercetin as a Bitter Taste Receptor Agonist with Anticancer Effects in Head and Neck Cancer Cells
Background/Objectives:
Quercetin is a bitter compound with demonstrated anticancer effects in preclinical models of head and neck squamous cell carcinoma (HNSCC). In taste transduction, bitter compounds activate bitter taste receptors (T2Rs), a group of G protein-coupled receptors with downstream signaling that includes cytosolic calcium (Ca 2+ ) release. T2Rs are expressed in HNSCC cells, where their activation induces apoptosis in vitro . Increased T2R expression in HNSCC also correlates with improved patient survival. The objective of this study was to investigate the role of quercetin as an anticancer T2R agonist in HNSCC cells in vitro and ex vivo .
Methods:
Quercetin-mediated Ca 2+ responses were assessed using live cell Ca 2+ imaging in the presence of the T2R14 antagonist LF1 and G-protein inhibitor YM-254980 (YM) in UM-SCC-47 and FaDu HNSCC cell lines. Cell viability was evaluated using crystal violet assays in cell lines and MTS assays in patient-derived tumor slices. Mitochondrial depolarization was measured with TMRE in the presence and absence of T2R pathway inhibitors.
Results:
Quercetin induced a Ca 2+ response in HNSCC cells, which was significantly reduced by LF1 and YM. Quercetin also decreased cell viability in vitro and showed a potential decrease in viability in tumor slices but was not statistically significant. Finally, quercetin caused mitochondrial depolarization, which was reduced in the presence of LF1 but not by YM.
Conclusions:
In HNSCC cells, quercetin causes a Ca 2+ response that is likely mediated by T2R14, decreases viability, and causes mitochondrial depolarization.
Insights
Quercetin, a compound found in plants, activates bitter taste receptors (T2Rs) in head and neck squamous cell carcinoma (HNSCC) cells. This activation reduces cancer cell viability and triggers mitochondrial depolarization, suggesting a potential anticancer role for quercetin in HNSCC.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Quercetin exhibits anticancer properties in preclinical models of head and neck squamous cell carcinoma (HNSCC).
- Bitter taste receptors (T2Rs) are expressed in HNSCC cells and their activation by bitter compounds like quercetin can induce apoptosis.
- Increased T2R expression in HNSCC correlates with improved patient survival.
Purpose of the Study:
- To investigate quercetin's role as an anticancer T2R agonist in HNSCC cells.
- To assess the effects of quercetin on calcium (Ca 2+ ) signaling, cell viability, and mitochondrial function in HNSCC.
Main Methods:
- Calcium imaging was used to assess quercetin-mediated Ca 2+ responses in HNSCC cell lines, with and without T2R14 antagonist LF1 and G-protein inhibitor YM-254980 (YM).
- Cell viability was evaluated using crystal violet and MTS assays in cell lines and patient-derived tumor slices.
- Mitochondrial depolarization was measured using TMRE in the presence and absence of T2R pathway inhibitors.
Main Results:
- Quercetin induced a significant Ca 2+ response in HNSCC cells, which was attenuated by LF1 and YM.
- Quercetin reduced cell viability in vitro and showed a trend towards decreased viability in tumor slices.
- Quercetin treatment led to mitochondrial depolarization, an effect reduced by LF1 but not YM.
Conclusions:
- Quercetin elicits a Ca 2+ response in HNSCC cells, likely mediated by T2R14.
- Quercetin decreases HNSCC cell viability and induces mitochondrial depolarization.
- These findings support quercetin's potential as an anticancer agent targeting T2Rs in HNSCC.
More Related Videos
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
The Physiology of Taste
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Inhibition of Cdk Activity
Cancer Prevention
Some...

